IL17A and COVID-19: To better define the response of the human nasal epithelium to IL17, we reanalyzed a subset of 15 healthy and 8 severe COVID-19 donors from our previously published population RNA-seq data that reflect gene expression in human nasal epithelial cells following in vitro exposure to a range of doses of IL17A (Fig. 3A and B) (36, 37).